Innate Pharma IPHA Income Statement (2017-2026)

NASDAQ IPHA
$1.58 +0.10 (+7.01%)
As of: Oct 20, 2026 · 3:59 PM EDT
Reported Financials

Innate Pharma Quarterly Income Statement

Periods 17 quarters
Latest Jun 2026

Innate Pharma reported net income of -$22.81M for the quarter ended Jun 2026. This income statement covers 17 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Operating items
Research & DevelopmentR&D -41.11M
Selling, General & AdministrativeSG&A -10.44M
Operating ExpensesOpex -51.55M
Non-operating items
Non Operating Interest Expenses -2.17M
Goodwill impairment chargesGoodwill Impair. -29.94M-74.01M-54.71M-58.59M-13.63M-55.11M-62.87M
Net income details
Income towards Parent CompanyParent Net Inc 3.48M-22.98M-11.38M-76.29M-28.56M-60.41M-59.28M-8.14M-26.67M-52.86M-24.16M-57.24M-22.81M
Net Income towards Common StockholdersNet Income 3.48M-22.98M-11.38M-76.29M-28.56M-60.41M-59.28M-8.14M-26.67M-52.86M-24.16M-57.24M-22.81M
Additional items
EPS (Basic) 0.06-0.34-0.17-0.97-0.36-0.76-0.74-0.10-0.33-0.65-0.30-0.64-0.25
Shares Outstanding 54.35M58.78M58.78M66.91M66.91M78.93M78.93M79.54M79.54M79.64M79.64M80.45M80.45M81.05M81.05M89.59M89.59M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 57.61M63.94M78.58M78.99M79.54M79.54M80.45M83.83M93.72M
Interest ExpensesInt Expense -2.17M

Innate Pharma Income Statement API

Pull Innate Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IPHA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY